Jennifer Kayden Lee, EVP, Head of North America: Rhythm Pharmaceuticals RYTM Sell · Filed 24/11/13

Trade details

Type: Insider sale
Amount: $2,499,189.68
Shares · price: 38,051 sh · $65.68 a share
Held after: 29,782 sh
Stock: Rhythm Pharmaceuticals RYTM
Person: Jennifer Kayden LeeEVP, Head of North America
Trade date: 24/11/11
Filed: 24/11/13
Days to filing: 2 days

Sold 56.1% of holdings

Share of holding sold: 56.1%

Rhythm Pharmaceuticals trades, last 26 weeks

What else happened in Rhythm Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/10/12~24/12/11

Jennifer Kayden Lee's recent trades

Jennifer Kayden LeeEVP, Head of North America
Planned sale10b5-1 planRhythm Pharmaceuticals
Planned sale10b5-1 plan
Rhythm Pharmaceuticals
RYTM
$8.9M
75,834 sh
$8.9M
Filed 08/13
Traded 08/13
Jennifer Kayden LeeEVP, Head of North America
Sell10b5-1 planRhythm Pharmaceuticals
Sell10b5-1 plan
Rhythm Pharmaceuticals
RYTM
$116.4K
2,035 sh
$116.4K
Filed 25/02/19
Traded 25/02/19
Jennifer Kayden LeeEVP, Head of North America
Sell10b5-1 planRhythm Pharmaceuticals
Sell10b5-1 plan
Rhythm Pharmaceuticals
RYTM
$69.9K
1,205 sh
$69.9K
Filed 25/02/14
Traded 25/02/13
Jennifer Kayden LeeEVP, Head of North America
Sell10b5-1 planRhythm Pharmaceuticals
Sell10b5-1 plan
Rhythm Pharmaceuticals
RYTM
$67.9K
1,205 sh
$67.9K
Filed 25/02/14
Traded 25/02/12
Jennifer Kayden LeeEVP, Head of North America
Sell10b5-1 planRhythm Pharmaceuticals
Sell10b5-1 plan
Rhythm Pharmaceuticals
RYTM
$33.8K
600 sh
$33.8K
Filed 25/02/14
Traded 25/02/12

Jennifer Kayden Lee, EVP — sold $2.5M of Rhythm Pharmaceuticals RYTM · 56.1% of holdings · 10b5-1 plan | Whalegun